XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Loss Per Common Share
9 Months Ended
Mar. 31, 2021
Loss Per Common Share  
Loss Per Common Share

Note 14. Loss Per Common Share

A reconciliation of the Company’s basic and diluted loss per common share was as follows:

Three Months Ended

March 31, 

(In thousands, except share and per share data)

    

2021

    

2020

Numerator:

Net loss

 

$

(7,142)

 

$

(16,592)

Interest expense applicable to the Convertible Notes, net of tax

 

 

Amortization of debt issuance costs applicable to the Convertible Notes, net of tax

 

 

Adjusted “if-converted” net loss

 

$

(7,142)

 

$

(16,592)

Denominator:

Basic weighted average common shares outstanding

 

39,511,296

 

38,707,049

Effect of potentially dilutive options and restricted stock awards

 

 

Effect of conversion of the Convertible Notes

 

 

Diluted weighted average common shares outstanding

 

39,511,296

 

38,707,049

Loss per common share:

Basic

 

$

(0.18)

 

$

(0.43)

Diluted

 

$

(0.18)

 

$

(0.43)

Nine Months Ended

March 31, 

(In thousands, except share and per share data)

    

2021

    

2020

Numerator:

Net loss

 

$

(185,589)

 

$

(23,665)

Interest expense applicable to the Convertible Notes, net of tax

 

 

Amortization of debt issuance costs applicable to the Convertible Notes, net of tax

 

 

Adjusted “if-converted” net loss

 

$

(185,589)

 

$

(23,665)

Denominator:

Basic weighted average common shares outstanding

 

39,340,670

 

38,539,850

Effect of potentially dilutive options and restricted stock awards

 

 

Effect of conversion of the Convertible Notes

 

 

Diluted weighted average common shares outstanding

 

39,340,670

 

38,539,850

Loss per common share:

Basic

 

$

(4.72)

 

$

(0.61)

Diluted

 

$

(4.72)

 

$

(0.61)

The number of anti-dilutive shares that have been excluded in the computation of diluted loss and earnings per share for the three months ended March 31, 2021 and 2020 were 8.1 million and 7.8 million, respectively. The number of anti-dilutive shares that have been excluded in the computation of diluted loss and earnings per share for the nine months ended March 31, 2021 and 2020 were 8.1 million and 6.0 million, respectively. The effect of potentially dilutive shares was excluded from the calculation of diluted loss per share in the three and nine months ended March 31, 2021 and 2020 because the effect of including such securities would be anti-dilutive.